Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
This one is special and different because it works on three different receptors, says Jessica Duncan, MD, DABOM, DABA, board-certified obesity medicine physician and Chief Medical Officer at Ivim Health
This injectable medication is classified as a Glucagon-Like Peptide 1 (GLP-1) receptor agonist, acting similarly to the hormone GLP-1
A: Many patients notice improvements in blood sugar and appetite within the first few weeks
Therefore, compounded drugs should only be used to meet a patients needs if the patients medical needs cannot be met by an available FDA-approved drug
GLP-1 RAs reduced LDL cholesterol in multiple populations with metabolic disorders, including individuals with overweight or obesity and antipsychotic-treated psychotic disorders (Class IV
US$ 21.34
US$ 28.88
US$ 27.85
